Abatacept suppresses T cell activation, but how durable is its effect?
Research shows its inhibitory impact is short-lived in vivo, diminishing significantly once treatment stops š§¬
š vist.ly/55mmj
#Immunology #Tcells #Autoimmunity
Abstract. Abatacept, a co-stimulatory blocker comprising the extracellular portion of human CTLA-4 linked to the Fc region of IgG1, is approved for the tre
